Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pelabresib DDI Study with Phenytoin and Itraconazole in Healthy Participants
NCT07783503Phase 1Recruiting
- Sponsor
- Novartis
- Start
- Sep 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of pelabresib (2 arms), sponsored by Novartis. Primary endpoints: Maximum observed plasma concentration, Area under the plasma concentration-time curve from time 0 to the last measurable concentration and 2 more. Started Sep 2026; status: recruiting.
02
Drugs
pelabresib
Beyond the preview
Go deeper on NCT07783503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07783503.